These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1096219)

  • 1. [Effects of (--)delta-9-trans-tetrahydrocannabinol (delta-9-THC) on tests of psychoticism. A study of Eysenck's drug postulate on the effects of hallucinogens in relation to psychoticism (author's transl)].
    Dittrich A; Bickel P; Zimmer D
    Psychopharmacologia; 1975; 40(4):351-8. PubMed ID: 1096219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of N,N-dimethyltryptamine (DMT) on tests of psychoticism (author's transl)].
    Bickel P; Dittrich A; Schöpf J
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Jan; 10(1):10-4. PubMed ID: 329291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cannabidiol on delta-9-tetrahydrocannabinol effects.
    Dalton WS; Martz R; Lemberger L; Rodda BE; Forney RB
    Clin Pharmacol Ther; 1976 Mar; 19(3):300-9. PubMed ID: 770048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of (-)delta 9-trans-tetrahydrocannabinol (delta 9-THC) on memory, attention and subjective state. A double blind study.
    Dittrich A; Bättig K; von Zeppelin I
    Psychopharmacologia; 1973 Dec; 33(4):369-76. PubMed ID: 4590954
    [No Abstract]   [Full Text] [Related]  

  • 5. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.
    Henquet C; Rosa A; Krabbendam L; Papiol S; Fananás L; Drukker M; Ramaekers JG; van Os J
    Neuropsychopharmacology; 2006 Dec; 31(12):2748-57. PubMed ID: 16936704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
    Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
    J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The psychosis-like effects of Δ(9)-tetrahydrocannabinol are associated with increased cortical noise in healthy humans.
    Cortes-Briones JA; Cahill JD; Skosnik PD; Mathalon DH; Williams A; Sewell RA; Roach BJ; Ford JM; Ranganathan M; D'Souza DC
    Biol Psychiatry; 2015 Dec; 78(11):805-13. PubMed ID: 25913109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of physostigmine and delta-9-tetrahydrocannabinol in man.
    Freemon FR; Rosenblatt JE; EL-Yousef MK
    Clin Pharmacol Ther; 1975 Feb; 17(2):121-6. PubMed ID: 1091392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trial of oral delta-1-(trans)-tetrahydrocannabinol in reversible airways obstruction.
    Davies BH; Radcliffe S; Seaton A; Graham JD
    Thorax; 1975 Feb; 30(1):80-5. PubMed ID: 1124532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol.
    Hollister LE; Gillespie H
    Clin Pharmacol Ther; 1975 Jul; 18(1):80-3. PubMed ID: 1097148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of delta-9-tetrahydrocannabinol. An approach to the active metabolite hypothesis.
    Hollister LE; Gillespie HK
    Clin Pharmacol Ther; 1975 Dec; 18(6):714-9. PubMed ID: 1204277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion.
    Benowitz NL; Jones RT
    Clin Pharmacol Ther; 1975 Sep; 18(3):287-97. PubMed ID: 1164818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.
    Pertwee RG
    Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade.
    Kanakis C; Pouget JM; Rosen KM
    Circulation; 1976 Apr; 53(4):703-7. PubMed ID: 1253395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression of growth hormone and cortisol response to insulin-induced hypoglycemia after prolonged oral delta-9-tetrahydrocannabinol administration in man.
    Benowitz NL; Jones RT; Lerner CB
    J Clin Endocrinol Metab; 1976 May; 42(5):938-41. PubMed ID: 1270583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divided attention performance of cannabis users and non-users following cannabis and alcohol.
    Macavoy MG; Marks DF
    Psychopharmacologia; 1975 Oct; 44(2):147-52. PubMed ID: 1105631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of altered states of consciousness induced by the hallucinogens (--)-delta9-trans-tetrahydrocannabinol (delta9-THC) and N,N-dimethyltryptamine (DMT) (author's transl)].
    Dittrich A; Bickel P; Schöpf J; Zimmer D
    Arch Psychiatr Nervenkr (1970); 1976 Dec; 223(1):77-87. PubMed ID: 1070948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
    Goodwin RS; Gustafson RA; Barnes A; Nebro W; Moolchan ET; Huestis MA
    Ther Drug Monit; 2006 Aug; 28(4):545-51. PubMed ID: 16885723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice.
    Chesher GB; Dahl CJ; Everingham M; Jackson DM; Marchant-Williams H; Starmer GA
    Br J Pharmacol; 1973 Dec; 49(4):588-94. PubMed ID: 4788032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Acute Δ
    Bloomfield MAP; Petrilli K; Lees R; Hindocha C; Beck K; Turner RJ; Onwordi EC; Rane N; Lythgoe DJ; Stone JM; Curran HV; Howes OD; Freeman TP
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):660-667. PubMed ID: 34099186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.